Seattle Genetics (SGEN) Misses Q3 EPS by 1c
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Revenue Growth %: -100.0%
Financial Fact:
Net income (loss): -31.75M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -100.0%
Financial Fact:
Net income (loss): -31.75M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $84.1 million versus the consensus estimate of $82.67 million.
ADCETRIS sales in the third quarter of $59.1 million, an increase from $48.2 million in the third quarter of 2014. For the year-to-date, ADCETRIS sales were $163.0 million, compared to $131.7 million for the year-to-date period in 2014, a 24 percent increase
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- P.A.M. Transportation Services (PTSI) Misses Q1 EPS by 9c
- United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!